The Locator -- [(subject = "Drug development--United States")]

32 records matched your query       


Record 11 | Previous Record | MARC Display | Next Record | Search Results
Author:
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Title:
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
Publisher:
National Academies Press,
Copyright Date:
c2012
Description:
xvi, 115 p. ; 23 cm.
Subject:
United States.--Cures Acceleration Network.--National Center for Advancing Translational Sciences.--Cures Acceleration Network.
Drug monitoring.
Drug development--United States.
Drugs--United States--Design.
Pharmaceutical industry--United States--Quality control.
Other Authors:
Olson, Steve, 1956-
Claiborne, Anne B.
Notes:
Includes bibliographical references (p. 71).
Contents:
Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
Summary:
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
ISBN:
9780309261166
0309261163
OCLC:
(OCoLC)811963294
Locations:
USUX851 -- Iowa State University - Parks Library (Ames)

Initiate Another SILO Locator Search

This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.